(IN BRIEF) AstraZeneca has revealed the eight winners of its 2023 R&D Postdoctoral Challenge, an initiative that supports early-career scientists in pursuing their innovative research proposals. Unlike traditional industry postdoctoral programs, this unique challenge allows researchers from around the world … Read the full press release
(IN BRIEF) The European Investment Bank (EIB) has announced a substantial investment of €500 million to support the eradication of polio in Africa and Asia. This landmark commitment was unveiled during a press conference in Brussels, signifying a historic partnership … Read the full press release
Posted in Banks, Business, Education, Environment, European Union, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, Media, News, Science, Technology
Tagged Africa, ASIA, Bill and Melinda Gates Foundation, Bill Gates, EIB, Eradicate Polio, European Commission, investment, partnership, President Werner Hoyer, sustainability, UNICEF, World Health Organization (WHO)
(IN BRIEF) The European Commission, the European Investment Bank (EIB), and the Bill & Melinda Gates Foundation have unveiled a groundbreaking financing partnership aimed at addressing global health challenges. The partnership, with support from the World Health Organization (WHO) and … Read the full press release
Posted in Banks, Business, Education, European Union, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Technology
Tagged Bill & Melinda Gates Foundation, Bill Gates, Catherine Russell, Dr Tedros Adhanom Ghebreyesus, EIB, Eradicate Polio, European Commission, health innovation, Melinda French Gates, partnership, sustainability, UNICEF, Ursula von der Leyen, Werner Hoyer, WHO
(IN BRIEF) AstraZeneca is set to present new data at the 12th annual IDWeek conference, emphasizing the role of long-acting antibodies and vaccines in safeguarding at-risk individuals from common infectious respiratory diseases. The company will share 15 abstracts, including oral … Read the full press release
(IN BRIEF) Alexion, a subsidiary of AstraZeneca Rare Disease, is set to present new data at the 9th Joint Meeting of the European Committee for Treatment and Research in Multiple Sclerosis and Americas Committee for Treatment and Research in Multiple … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Alexion, Alize Vives, Anna Francis, AQP4, AstraZeneca, Christophe Hotermans, ECTRIMS-ACTRIMS Meeting, effectiveness, Jin Nakahara, Justin Lee, Michael Levy, multiple sclerosis, NMOSD, Rare Neurological Disorder, rituximab, Sami Fam, Soliris, treatment, Ultomiris, Viktoria Papp
(IN BRIEF) AstraZeneca has unveiled data from four pivotal Phase III trials at the European Society for Medical Oncology (ESMO) Congress, demonstrating advances in cancer treatments across multiple types of cancers. These trials include TROPION-Lung01 and TROPION-Breast01, showcasing the significance … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AstraZeneca, breast cancer, cancer treatments, datopotamab deruxtecan, Dave Fredrickson, DESTINY-PanTumor02, DUO-E, ESMO Congress, FLAURA2, gastrointestinal cancer, Imfinzi, lung cancer, MATTERHORN, Phase III Trials, Susan Galbraith, Tagrisso, TROPION-Breast01, TROPION-Lung01
(IN BRIEF) Atos has been chosen by Ambu, a leading provider of single-use endoscopy solutions, as its IT infrastructure partner to support Ambu’s global digital transformation. Atos will provide end-to-end IT infrastructure services, contributing to Ambu’s IT transformation efforts aimed … Read the full press release
Posted in Business, Denmark, Healthcare, Industrial, Management, News, Science, Technology
Tagged Agnetha Mattisson, Ambu, Atos, digital transformation, endoscopy, Harri Saikkonen, IT infrastructure
(IN BRIEF) Roche has announced positive late-breaking data from the Phase III OCARINA II study, which demonstrates the effectiveness of OCREVUS as a twice-yearly, 10-minute subcutaneous injection for patients with relapsing or primary progressive multiple sclerosis (RMS or PPMS). The … Read the full press release
(IN BRIEF) Merck has presented new data on evobrutinib, an investigational BTK inhibitor, at the 9th Joint ECTRIMS-ACTRIMS congress. The data from an ongoing Phase II open-label extension study of evobrutinib in patients with relapsing multiple sclerosis (RMS) show sustained … Read the full press release
Posted in Business, Education, Germany, Healthcare, Industrial, Management, News, Pharma & Biotech, Science
Tagged BTKi, Evobrutinib, Jan Klatt, Merck, multiple sclerosis, relapsing multiple sclerosis (RMS), treatment
(IN BRIEF) GlaxoSmithKline (GSK) has announced a confidential settlement in the Cantlay/Harper case filed in California state court, which was scheduled for trial in November 2023. Additionally, GSK has settled the three remaining breast cancer bellwether cases in California, effectively … Read the full press release
Posted in Business, Government, Healthcare, Industrial, Law, Management, News, Pharma & Biotech, Science, United Kingdom
Tagged breast cancer, California, Confidential Settlements, GSK, litigation, Zantac
(IN BRIEF) During the Welcome Ceremony of the XXIII FIGO World Congress of Gynecology and Obstetrics in Paris, FIGO (International Federation of Gynecology and Obstetrics) celebrated the contributions of five exceptional professionals dedicated to improving women’s health worldwide. The FIGO … Read the full press release
Posted in Awards, Business, Healthcare, Industrial, Management, Media, News, Science, Society, United Kingdom
Tagged Awards, Dr. Anshu Banerjee, Dr. Barbara Demeneix, Dr. Willy Davila, FIGO, leadership, Professor Bo Jacobsson, Professor Pascale Allotey, Women's Health Champions, XXIII World Congress
(IN BRIEF) Merck, a prominent science and technology company, has revealed new findings from the MAVENCLAD® (cladribine tablets) MAGNIFY-MS study at the 9th Joint ECTRIMS-ACTRIMS meeting in Milan. The study demonstrated that patients with relapsing multiple sclerosis (RMS) experienced a … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, Management, News, Pharma & Biotech, Science
Tagged Alexander Kulla, MAVENCLAD, Merck, multiple sclerosis, Neuronal Injury, reduction
(IN BRIEF) Launched on World Mental Health Day, this 10-week blended course, developed in collaboration with the IFRC Reference Centre for Psychosocial Support, aims to provide essential skills for individuals involved in the development, management, and monitoring of mental health … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Ireland, Management, News, Science, Society
Tagged awareness, Dr Meg Ryan, Dr. Frédérique Vallières, humanitarian emergencies, mental health, partnership, PS Centre, psychosocial, Sarah Harrison, support, sustainability, Trinity College Dublin, World Mental Health Day
(IN BRIEF) Almirall, a global biopharmaceutical company specializing in medical dermatology, has entered into an agreement with Centrient Pharmaceuticals, a leader in sustainable biosynthetic pharmaceuticals, to establish a dedicated innovation lab at Almirall’s R&D center in Sant Feliu de Llobregat, … Read the full press release
Posted in Business, Education, Environment, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Spain, Technology
Tagged Almirall, Barcelona, Centrient Pharmaceuticals, Innovation Lab, Jorge Gil-Martinez, Karl Ziegelbauer, medical dermatology, partnership, R&D center, Rex Clements, sustainability
(IN BRIEF) EQT is set to acquire VetPartners, the largest provider of veterinary services in Australia and New Zealand, from National Veterinary Associates, Inc. Through this deal, EQT plans to support VetPartners’ clinical teams in delivering top-quality care to animals. … Read the full press release
(IN BRIEF) Bayer has invested $250 million in a new cell therapy production plant in Berkeley, California, USA. This investment aims to support the production of materials for clinical trials and potential commercial launches of BlueRock Therapeutics’ bemdaneprocel (BRT-DA01), an … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science
Tagged Bayer, Bemdaneprocel, Berkeley, BRT-DA01, California, Cell Therapy Plant, Holger Weintritt, Parkinson's disease, partnership, Seth Ettenberg, Stefan Oelrich, sustainability, USA
(IN BRIEF) Fujirebio Holdings and Sysmex Corporation have entered into a Basic Agreement on Business Collaboration in the field of immunoassay. This collaboration will involve various aspects such as research and development, production, clinical development, and sales-marketing. Sysmex, known for … Read the full press release
Posted in Belgium, Business, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Fujirebio, Goki Ishikawa, Immunoassay Technology, partnership, sustainability, Sysmex
(IN BRIEF) Eni CEO Claudio Descalzi and Dompé farmaceutici Executive Chairman Sergio Dompé have signed a Letter of Intent to initiate joint research and development efforts focused on public health and community well-being in regions where Eni operates, along with … Read the full press release
(IN BRIEF) GSK plc has announced an exclusive agreement with Chongqing Zhifei Biological Products, Ltd. (Zhifei) to co-promote GSK’s shingles vaccine, Shingrix, in China for an initial three-year period, with the potential for extension. Zhifei, China’s largest vaccine company by … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, United Kingdom
Tagged CHINA, GSK, Luke Miels, partnership, Shingles, Shingrix Vaccine, Zhifei
(IN BRIEF) EQT, a prominent investment firm, welcomes Maarten de Jong and Mark Braganza as new Partners to its Healthcare team, based in London. EQT, with a 30-year history of investing in healthcare companies, supports companies across various growth stages … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Sweden, United Kingdom
Tagged appointments, EQT, Healthcare Team, leadership, London, Maarten de Jong, Mark Braganza, Michael Bauer, partnership
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?